Skip to main content

Table 3 Associations of serum asprosin levels with other clinical factors

From: Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study

Clinical data

R

P

Age

0.008

0.901

BMI

0.288

< 0.001

Time from T2DM diagnosis

0.068

0.314

SBP

-0.036

0.601

DBP

0.097

0.154

TC

0.010

0.881

TG

0.227

0.001

HDL-C

-0.109

0.108

LDL-C

0.021

0.758

ALT

0.116

0.087

AST

0.059

0.382

GGT

0.182

0.007

Scr

0.389

< 0.001

eGFR

-0.314

< 0.001

HbA1C

-0.063

0.354

FPG

-0.094

0.167

2hPG

-0.082

0.226

FINS

0.184

0.006

HOMA-IR

0.142

0.036

FC-P

-0.130

0.056

  1. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LCL-D, low-density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutaryl transferase; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; FPG, fasting plasma glucose; 2hPG, 2-hour postprandial glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance; FC-P, fasting C-peptide
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us